| ST002318 Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with trastuzumab | ||||
| Limit by pathway class: | ||||
| ST002318 Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with trastuzumab | ||||
| Limit by pathway class: | ||||
|